Axol are the Human iPSC-Derived cell culture specialists and produce high quality human cell products for the range of neuroscience and cardiovascular research needs. We have a passion for great science and a history of delivering innovative products to help our customers advance faster in their research.Our expertise includes reprogramming cells to iPSCs and then differentiating to various cell types. We supply differentiated cells derived from healthy donors and patients of specific disease backgrounds. As a service, we also take cells provided by customers (primary or iPSC) and then do the reprogramming (when necessary) and differentiation. Axol holds the necessary licenses that are required to do iPSC work.The package wouldn't be complete without optimized media, coating solutions and other reagents. Our in-house R&D team works hard to improve on existing media and reagents as well as continuing the drive for new products to support cutting edge research.
Wednesday, 18th November, 2020
10:00am GMT (UTC+0)
hosted by Lilly Xu, Ph.D. Senior Vice President, DMPK & Exploratory Toxicology Dept, ChemPartner